Citigroup Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $14.00
Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) had its price target increased by stock analysts at Citigroup from $12.00 to $14.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s target price indicates a potential upside of 126.57% from the company’s current price. Other equities analysts […]
25 Feb 15:14 · The Cerbat Gem